ENDPOINTS

Idorsia’s Tryvio licensing negotiations collapse amid cash squeeze

Idorsia’s plan to hand over the global rights to its blood pressure drug Tryvio has ended in disappointment after a deal announced in November fell through. The Swiss drugmaker said Thursday ...

Feb 13, 2025 - 16:39
 0
Idorsia’s Tryvio licensing negotiations collapse amid cash squeeze
Idorsia’s plan to hand over the global rights to its blood pressure drug Tryvio has ended in disappointment after a deal announced in November fell through. The Swiss drugmaker said Thursday ...
Read More

Tags:

Previous Article

Webb Maps Full Picture of How Phoenix Galaxy Cluster Forms Stars

Next Article

Allay Therapeutics raises $45M for ongoing Series D; Encoded’s layoffs

Related Posts

#ASCOGU: Pfizer’s prostate cancer data leak shows promising results in early-stage study

#ASCOGU: Pfizer’s prostate cancer data leak shows promi...

Feb 11, 2025  0

What will pharma's share buyback shopping spree mean for M&A?

What will pharma's share buyback shopping spree mean fo...

Feb 11, 2025  0

J&J, Intra-Cellular quickly sealed $14B deal as three others passed on buying the neuro drugmaker

J&J, Intra-Cellular quickly sealed $14B deal as three o...

Feb 9, 2025  0